Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III/IV Melanoma”

543 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 543 results

Early research (Phase 1)Study completedNCT00085488
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Dartmouth-Hitchcock Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT04375527
What this trial is testing

Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC V8Clinical Stage IV Cutaneous Melanoma AJCC V8Locally Advanced Cutaneous Melanoma+8 more
Jonsson Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00027742
What this trial is testing

Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02857569
What this trial is testing

A Trial Evaluating the Safety & Efficacy of Intra-Tumoral Ipilimumab in Combination With Intra-venous Nivolumab in Patients With Metastatic Melanoma

Who this might be right for
Stage III/IV Melanoma
Gustave Roussy, Cancer Campus, Grand Paris 90
Testing effectiveness (Phase 2)Study completedNCT00005961
What this trial is testing

O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI) 40
Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Early research (Phase 1)WithdrawnNCT06626256
What this trial is testing

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Who this might be right for
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
City of Hope Medical Center
Not applicableStudy completedNCT01715077
What this trial is testing

Study of Ipilimumab in the Immune System

Who this might be right for
Previously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma
University Health Network, Toronto 4
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Early research (Phase 1)Study completedNCT00815607
What this trial is testing

Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma

Who this might be right for
Melanoma
Alaunos Therapeutics 12
Not applicableLooking for participantsNCT05527795
What this trial is testing

Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma

Who this might be right for
Melanoma
Hospices Civils de Lyon 1,000
Early research (Phase 1)Study completedNCT00698100
What this trial is testing

Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines

Who this might be right for
MelanomaSkin
Memorial Sloan Kettering Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00257465
What this trial is testing

Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma

Who this might be right for
Melanoma
AVAX Technologies 82
Testing effectiveness (Phase 2)Looking for participantsNCT05655312
What this trial is testing

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

Who this might be right for
Recurrent Melanoma (Skin)Metastatic MelanomaMelanoma Stage IV+1 more
Perspective Therapeutics 300
Testing effectiveness (Phase 2)Study completedNCT00243594
What this trial is testing

Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection

Who this might be right for
Melanoma Stage III or IV
Radboud University Medical Center 40
Testing effectiveness (Phase 2)UnknownNCT00086866
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 165
Testing effectiveness (Phase 2)UnknownNCT02142335
What this trial is testing

Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma

Who this might be right for
Malignant Melanoma of Skin Stage IIIMetastatic Melanoma
California Cancer Assocaties for Research & Excellence 17
Testing effectiveness (Phase 2)Study completedNCT00003989
What this trial is testing

ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma

Who this might be right for
Lung CancerMelanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 50
Testing effectiveness (Phase 2)Ended earlyNCT01942993
What this trial is testing

The Effects of Treatment With Vemurafenib on the Immune System in Advanced Melanoma

Who this might be right for
Melanoma
Philip Friedlander 3
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Next Page